02:13 ET Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE
I'm PortAI, I can summarize articles.
The DJS Law Group has announced a class action lawsuit against Skye Bioscience, Inc. (NASDAQ: SKYE) for securities law violations, specifically for making false and misleading statements regarding its product, nimacimab. The class period is from November 4, 2024, to October 3, 2025, with a deadline for lead plaintiff appointments set for January 16, 2026. Shareholders who suffered losses during this period are encouraged to contact the firm for participation in the lawsuit.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: prnewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments